To hear about similar clinical trials, please enter your email below
Trial Title:
The Effect of Frailty on Blood Biology Indicators, Quality of Life and Survival of Patients With Radical Prostatectomy
NCT ID:
NCT05941104
Condition:
Prostatic Neoplasms
Frailty
Blood Biological Indicators
Quality of Life
Survival
Conditions: Official terms:
Prostatic Neoplasms
Frailty
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
frailty
Description:
Frailty is a group of common clinical syndromes in the elderly, characterized by
systematic, dynamic and reversible, the core of which is the decline of physiological
reserves and the destruction of self-balance.
Arm group label:
Frail group
Summary:
The goal of this observational study is to evaluate the effect of frailty on blood
biology indicators, quality of life and survival of patients with radical prostatectomy.
The main questions it aims to answer are:
1. Evaluate the impact of frailty on the blood biological indicators, quality of life
and survival of patients with radical prostatectomy, specifically.
2. Describe the longitudinal changes in the quality of life of patients with radical
prostatectomy.
Participants will be divided into frail group or non-frail group based on frailty
assessment. Researchers will compare the two groups to see the impact of frailty on the
blood biological indicators, quality of life and survival.
Criteria for eligibility:
Study pop:
Prostate cancer patients with Radical Prostatectomy.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
1. Diagnosed with prostate cancer (be diagnosed by relevant imaging examinations or
pathology);
2. Radical prostatectomy is planned;
3. Voluntarily sign the informed consent form.
Exclusion Criteria:
1. Diagnosed with other malignant tumors at the same time;
2. Patients with acute infection.
Gender:
Male
Minimum age:
60 Years
Maximum age:
N/A
Start date:
July 15, 2023
Completion date:
December 31, 2025
Lead sponsor:
Agency:
Anhui Provincial Hospital
Agency class:
Other
Source:
Anhui Provincial Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05941104
